CLIA Kit for Triiodothyronine (T3)

78.1-20, 000pg/mL

The minimum detectable dose of this kit is typically less than 25.9pg/mL

2h

This assay has high sensitivity and excellent specificity for detection of Triiodothyronine (T3).
No significant cross-reactivity or interference between Triiodothyronine (T3) and analogues was observed.

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

The microplate provided in this kit has been pre-coated with a monoclonal antibody specific to Triiodothyronine (T3). A competitive inhibition reaction is launched between biotin labeled Triiodothyronine (T3) and unlabeled Triiodothyronine (T3) (Standards or samples) with the pre-coated antibody specific to Triiodothyronine (T3). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Triiodothyronine (T3) in the sample. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is reverse proportional to the Triiodothyronine (T3) level in the sample or standard.

Exposure of pregnant mice to perfluorobutanesulfonate causes hypothyroxinemia and developmental abnormalities in female offspring; Endemic goitre in the Sudan despite longstanding programmes for the control of iodine deficiency disorders; Neuroprotective effects of thymoquinone against cerebellar histopathological changes in propylthiouracil-induced hypothyroidism in adult rats;